These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341 [TBL] [Abstract][Full Text] [Related]
11. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320 [TBL] [Abstract][Full Text] [Related]
12. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Li JS; Turgeon A; Schiffrin EL Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791 [TBL] [Abstract][Full Text] [Related]
13. Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension. Li L; Galligan JJ; Fink GD; Chen AF Hypertension; 2003 Mar; 41(3 Pt 2):663-8. PubMed ID: 12623976 [TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Li L; Fink GD; Watts SW; Northcott CA; Galligan JJ; Pagano PJ; Chen AF Circulation; 2003 Feb; 107(7):1053-8. PubMed ID: 12600921 [TBL] [Abstract][Full Text] [Related]
15. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats. Giulumian AD; Pollock DM; Clarke N; Fuchs LC Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015 [TBL] [Abstract][Full Text] [Related]
16. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Schiffrin EL; Turgeon A; Deng LY Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550 [TBL] [Abstract][Full Text] [Related]
17. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats. Nakano D; Itoh C; Ishii F; Kawanishi H; Takaoka M; Kiso Y; Tsuruoka N; Tanaka T; Matsumura Y Biol Pharm Bull; 2003 Dec; 26(12):1701-5. PubMed ID: 14646174 [TBL] [Abstract][Full Text] [Related]
18. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Somers MJ; Mavromatis K; Galis ZS; Harrison DG Circulation; 2000 Apr; 101(14):1722-8. PubMed ID: 10758056 [TBL] [Abstract][Full Text] [Related]
19. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Zheng JS; Yang XQ; Lookingland KJ; Fink GD; Hesslinger C; Kapatos G; Kovesdi I; Chen AF Circulation; 2003 Sep; 108(10):1238-45. PubMed ID: 12925450 [TBL] [Abstract][Full Text] [Related]
20. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]